1-5 of 5
Andrew P. Feinberg
Close
Sort by
Journal Articles

Mutant WT1 is associated with DNA hypermethylation of PRC2 targets in AML and responds to EZH2 inhibition

Subarna Sinha, Daniel Thomas, Linda Yu, Andrew J. Gentles, Namyoung Jung, M. Ryan Corces-Zimmerman, Steven M. Chan, Andreas Reinisch, Andrew P. Feinberg, David L. Dill, Ravindra Majeti
Journal: Blood
Blood (2015) 125 (2): 316–326.
https://doi.org/10.1182/blood-2014-03-566018
Published: 2015
Includes: Supplemental data
Journal Articles

Epigenetic Signature of Leukemia Stem Cells Defines Subgroups Associated with Clinical Outcome and Cell of Origin in AML

Namyoung Jung, BS, Bo Dai, PhD, Andrew J. Gentles, PhD, Peter Murakami, MSc, Ravindra Majeti, MD PhD, Andrew P. Feinberg, MD
Journal: Blood
Blood (2014) 124 (21): 2147.
https://doi.org/10.1182/blood.V124.21.2147.2147
Published: 2014
Journal Articles

Mutation in Wilms' Tumor 1 Induces DNA Hypermethylation of PRC2 Targets, Blocks Myelomonocytic Differentiation, and Defines a Novel Subtype of AML Responsive to EZH2 Inhibition

Daniel Thomas, MD PhD, Subarna Sinha, PhD, Linda Yu, Namyoung Jung, BS, Bo Dai, PhD, Andrew J Gentles, PhD, Andrew P. Feinberg, MD, David Dill, PhD, Ravindra Majeti, MD PhD
Journal: Blood
Blood (2014) 124 (21): 780.
https://doi.org/10.1182/blood.V124.21.780.780
Published: 2014
Journal Articles

Epigenetics of Hematopoiesis, Stem Cell Reprogramming, and Cancer

Andrew P. Feinberg, MD
Journal: Blood
Blood (2013) 122 (21): SCI-47.
https://doi.org/10.1182/blood.V122.21.SCI-47.SCI-47
Published: 2013
Journal Articles

Loss of Imprinting in Disease Progression in Chronic Myelogenous Leukemia

Gurvaneet S. Randhawa, Hengmi Cui, Janet A. Barletta, Liora Z. Strichman-Almashanu, Moshe Talpaz, Hagop Kantarjian, Albert B. Deisseroth, Richard C. Champlin, Andrew P. Feinberg
Journal: Blood
Blood (1998) 91 (9): 3144–3147.
https://doi.org/10.1182/blood.V91.9.3144
Published: 1998